Read + Share
Amedeo Smart
Independent Medical Education
Han J, Bilgrami S, Ross S, Broadhead H, et al. Real-world lipid lowering effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: A single-centre study. Int J Cardiol 2021;322:240-244.PMID: 32827563
Email
LinkedIn
Facebook
Twitter
Privacy Policy